Mexican Institute of Social Security. Guadalajara Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2007
NCT01030614
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Full-time Surgical Researcher and Professor of Surgery. Surgical Research Unit. Specialties Hospital. Mexican Institute of Social Security. Guadalajara, Jal. Mexico

Active Ingredients

Drugs in Phase 3 Trials (1)

urea (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Fatigue (Phase 3)

Postoperative Nausea and Vomiting (Phase 3)

Vomiting (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1